Skip to main content
Interpace Biosciences, Inc. (MUN:PF42)
Germany flag Germany · Delayed Price · Currency is EUR
1.710
0.00 (0.00%)
Last updated: Apr 29, 2026, 8:02 AM CET

Interpace Biosciences Statistics

Total Valuation

MUN:PF42 has a market cap or net worth of EUR 45.67 million. The enterprise value is 44.54 million.

Market Cap 45.67M
Enterprise Value 44.54M

Important Dates

The last earnings date was Tuesday, April 14, 2026.

Earnings Date Apr 14, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 27.70M
Shares Outstanding n/a
Shares Change (YoY) +76.02%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 3.49%
Owned by Institutions (%) 0.52%
Float 3.47M

Valuation Ratios

The trailing PE ratio is 2.18.

PE Ratio 2.18
Forward PE n/a
PS Ratio 1.38
PB Ratio 2.40
P/TBV Ratio 2.40
P/FCF Ratio 9.79
P/OCF Ratio 9.20
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.99, with an EV/FCF ratio of 9.55.

EV / Earnings 2.13
EV / Sales 1.35
EV / EBITDA 8.99
EV / EBIT 10.92
EV / FCF 9.55

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.05.

Current Ratio 1.94
Quick Ratio 1.60
Debt / Equity 0.05
Debt / EBITDA 0.20
Debt / FCF 0.22
Interest Coverage 28.48

Financial Efficiency

Return on equity (ROE) is 248.03% and return on invested capital (ROIC) is 44.34%.

Return on Equity (ROE) 248.03%
Return on Assets (ROA) 12.30%
Return on Invested Capital (ROIC) 44.34%
Return on Capital Employed (ROCE) 16.65%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 323,379
Profits Per Employee 205,201
Employee Count 102
Asset Turnover 1.59
Inventory Turnover 12.56

Taxes

Income Tax -18.06M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.44
200-Day Moving Average n/a
Relative Strength Index (RSI) 100.00
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.43

Income Statement

In the last 12 months, MUN:PF42 had revenue of EUR 32.98 million and earned 20.93 million in profits. Earnings per share was 0.75.

Revenue 32.98M
Gross Profit 20.55M
Operating Income 4.07M
Pretax Income 3.21M
Net Income 20.93M
EBITDA 4.44M
EBIT 4.07M
Earnings Per Share (EPS) 0.75

Balance Sheet

The company has 2.13 million in cash and 1.01 million in debt, giving a net cash position of 1.13 million.

Cash & Cash Equivalents 2.13M
Total Debt 1.01M
Net Cash 1.13M
Net Cash Per Share n/a
Equity (Book Value) 19.05M
Book Value Per Share 4.20
Working Capital 4.09M

Cash Flow

In the last 12 months, operating cash flow was 4.97 million and capital expenditures -303,205, giving a free cash flow of 4.66 million.

Operating Cash Flow 4.97M
Capital Expenditures -303,205
Depreciation & Amortization 362,856
Net Borrowing -3.76M
Free Cash Flow 4.66M
FCF Per Share n/a

Margins

Gross margin is 62.31%, with operating and profit margins of 12.35% and 63.46%.

Gross Margin 62.31%
Operating Margin 12.35%
Pretax Margin 9.74%
Profit Margin 63.46%
EBITDA Margin 13.45%
EBIT Margin 12.35%
FCF Margin 14.14%

Dividends & Yields

MUN:PF42 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -76.02%
Shareholder Yield -76.02%
Earnings Yield 45.83%
FCF Yield 10.21%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MUN:PF42 has an Altman Z-Score of -6.71 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.71
Piotroski F-Score 4